AMC-053: Pilot Study of an Oncolytic Viral Strategy Using Bortezomib with ICE +/- Rituximab for Relapsed/Refractory HIV+ Lymphomas
Year: 2016
Type: conference-abstract
Source: Blood
Institutions: University of California San Diego, Moores Cancer Center, VA San Diego Healthcare System, National Cancer Institute, Memorial Sloan Kettering Cancer Center, Pennsylvania Hospital, Virginia Mason Medical Center, University of Miami, Sylvester Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Arkansas for Medical Sciences, Ronald Reagan UCLA Medical Center, UCLA Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2560358251